Drug Overview
Alofisel (darvadstrocel; TiGenix/Takeda) is a suspension of allogeneic expanded adipose-derived stem cells via intralesional injection.
The therapy is being developed in Crohn’s disease for the treatment of complex perianal fistulas which show an inadequate response to at least one conventional or biologic therapy, including antibiotics, immunosuppressants, or anti-tumor necrosis factor (TNF) agents.
Alofisel (darvadstrocel; TiGenix/Takeda) is a suspension of allogeneic expanded adipose-derived stem cells via intralesional injection.
The therapy is being developed in Crohn’s disease for the treatment of complex perianal fistulas which show an inadequate response to at least one conventional or biologic therapy, including antibiotics, immunosuppressants, or anti-tumor necrosis factor (TNF) agents.
Table of Contents
OVERVIEW
LIST OF FIGURES
LIST OF TABLES